About Sermorelin
How does it work?
Sermorelin mimics the hypothalamic signal your brain sends to trigger GH release from the pituitary gland. It binds GHRH receptors on somatotroph cells in the anterior pituitary, triggering pulsatile GH secretion into the bloodstream. That GH travels to the liver, where it stimulates insulin-like growth factor 1 (IGF-1) production. IGF-1 is the downstream marker prescribers track to see whether the GH axis is responding.
Here’s the key distinction: sermorelin stimulates your body’s own GH production rather than supplying GH directly. The pituitary’s natural feedback system (somatostatin) stays active, so GH release stays pulsatile. That’s structurally different from exogenous human growth hormone (HGH), which bypasses the feedback loop entirely.
A few regulatory points matter here. Sermorelin acetate was originally FDA-approved only for diagnosing and treating growth hormone deficiency in children, as described in the Mayo Clinic’s sermorelin drug profile. That branded product was later withdrawn, so no FDA-approved version of sermorelin is on the US market today. The compounded sermorelin used for adult wellness is not FDA-approved for any indication, and the adult goals it’s discussed for (energy, sleep, body composition, recovery) aren’t supported by large randomized controlled trials. So this isn’t an “off-label” use of an approved drug; it’s a compounded preparation used without FDA approval.
Available forms
Subcutaneous injection is the primary and most-studied route. Most protocols call for nightly dosing. The timing isn’t random. Your largest natural GH pulse happens during slow-wave sleep, roughly one to two hours after you fall asleep. Bedtime dosing amplifies that pulse rather than creating an artificial one.
Some compounding pharmacies prepare sublingual (under-the-tongue) troches, oral capsules, and nasal spray formulations too. These forms exist but don’t have as much evidence behind them as the injectable route. Dose, strength, and formulation are set by your prescriber and compounding pharmacy. Rotate injection sites across the abdomen, hip, thigh, and upper arm.
Your Testing-to-Treatment Journey
Step 1: Lab tests to consider first
Baseline labs help a prescriber understand your GH axis before starting sermorelin. IGF-1 is the primary marker. Thyroid function and metabolic health both affect how well sermorelin works and whether it’s right for you.
| Test | Why it’s reviewed | What different results suggest |
| IGF-1 (Insulin-Like Growth Factor 1) | IGF-1 is the main downstream marker of GH axis activity; a low or low-normal IGF-1 for your age is the primary lab signal pointing toward GH-axis support | A low or low-normal IGF-1 relative to age-matched reference ranges suggests reduced GH axis activity, the pattern sermorelin is designed to address. A normal-to-high IGF-1 weakens the case for therapy. |
| Thyroid Panel (TSH, Free T4) | Thyroid hormone is required for normal GH axis function; untreated hypothyroidism blunts the pituitary’s response to GHRH, making sermorelin less effective | If thyroid function is low, a prescriber will usually address hypothyroidism first, not because it’s a contraindication, but because it reduces sermorelin’s effectiveness. Normal thyroid function supports GH axis responsiveness. |
| Fasting Glucose and Metabolic Panel | GH elevation can affect insulin sensitivity; baseline glucose and metabolic markers set your starting point and help track changes on therapy | High fasting glucose or signs of insulin resistance alongside low IGF-1 add metabolic context. A prescriber may use these values to check your metabolic health before starting a therapy that affects glucose handling. |
If your IGF-1 is low or low-normal for your age and your thyroid function is normal, a prescriber may discuss sermorelin as part of a broader GH-axis support plan. These patterns are context for a conversation, not a self-diagnosis checklist. Talk with a licensed provider before drawing conclusions from any single result.
Step 2: What happens during a prescriber consult
Your prescriber reviews your medical history, current medications, baseline labs (including IGF-1 and thyroid function), and wellness goals. They screen for contraindications including active malignancy, untreated hypothyroidism, and pregnancy. Both telehealth platforms and in-person clinics offer sermorelin evaluations. Candidacy is based on your clinical picture, not a standardized BMI threshold.
Step 3: Starting therapy
Most compounding pharmacy protocols start sermorelin at 100 to 300 mcg as a nightly subcutaneous injection. These ranges reflect common clinical practice, not FDA labeling, which covered a different pediatric indication at different doses.
Bedtime timing matters. Your body’s largest GH pulse happens during slow-wave sleep, about one to two hours after you fall asleep. Injecting at bedtime works with that natural rhythm. Rotate injection sites across the abdomen, hip, thigh, and upper arm to cut down on site irritation.
Dose gets adjusted over time based on your IGF-1 response, how you feel, and tolerance. Your prescriber and compounding pharmacy set the specific protocol.
Step 4: Labs to recheck on therapy
IGF-1 should rise toward the normal range for your age, but not above it. Track fasting glucose too. GH elevation can change how your body handles insulin over time. GH axis activity affects metabolic markers including glucose handling and insulin sensitivity over time.
Results are usually delivered one to two business days after the lab receives your sample.
| Recheck | Frequency | What it shows |
| IGF-1 | Every three to six months | GH axis response; confirms IGF-1 is rising toward the normal range for your age without going above it (high IGF-1 is a safety concern) |
| Fasting glucose | Every three to six months | Insulin sensitivity; GH elevation can impair glucose handling in some people |
| Thyroid panel | As clinically indicated | Confirms thyroid function stays stable; hypothyroidism developing on therapy can blunt sermorelin’s effect |
| Body composition / weight | Monthly to quarterly | Tracks lean mass and fat distribution changes over the treatment timeline |
From the Testing.com Medical Review Board
“With sermorelin, IGF-1 is the number we watch most closely. The goal is to bring a low or low-normal IGF-1 into the normal range for the patient’s age, not to push it above that range. If IGF-1 climbs above the upper limit of normal, that’s a signal to reduce the dose or pause therapy. Fasting glucose is the other marker worth tracking, since GH elevation can affect insulin sensitivity over time.”
Testing.com Editorial Review Board
Safety and Side Effects
Common side effects
Pain, redness, or swelling at the injection site is the most common side effect. It’s listed as “more common” in the FDA labeling for the original branded version of sermorelin acetate.
Systemic effects are rare. They include headache, flushing, dizziness, sleepiness, and trouble sitting still. Most of these are temporary. They tend to improve as your body adjusts.
Rare but worth knowing: itching and trouble swallowing. These may reflect a hypersensitivity reaction. Report them to your prescriber promptly.
How to manage them
Prescribers commonly recommend a few specific tactics:
- Injection-site reactions: Rotate sites across the abdomen, hip, thigh, and upper arm. Pinch the skin and insert at the right angle to reduce local irritation.
- Headache, flushing, dizziness: A dose reduction or timing change often helps if these persist beyond the first few weeks.
- Trouble swallowing or hypersensitivity reactions: Contact your prescriber right away. These are rare but listed in FDA labeling. Don’t manage them on your own.
Specific adjustments depend on your prescriber’s assessment.
Serious risks and contraindications
Cancer is the most important safety consideration here. Sermorelin works by raising GH and IGF-1, and higher IGF-1 levels have been linked to a greater risk of several cancers, including colorectal, breast, and prostate cancer. Growth hormone can also fuel the growth of tumors that are already present. For that reason, active cancer is a contraindication, and anyone with a personal history of cancer, not only active disease, should weigh this risk carefully with their prescriber, ideally with oncology input, before considering sermorelin.
Because sermorelin raises GH and IGF-1, it carries the dose-related risks of too much growth hormone. These include fluid retention and swelling (edema), joint aches, and higher blood sugar or reduced insulin sensitivity, which matters if you have diabetes or prediabetes. Pushing IGF-1 above the normal range, usually from excessive dosing, can cause acromegaly-like effects, which is why prescribers track IGF-1 and aim to keep it within the normal range for your age rather than above it.
Untreated hypothyroidism isn’t a hard contraindication, but it must be addressed first. Hypothyroidism blunts the pituitary’s response to GHRH, reducing sermorelin’s effectiveness. Pregnancy and breastfeeding are contraindications due to inadequate safety data, as is known hypersensitivity to sermorelin acetate. Discuss your full medical history with your prescriber before starting.
Sermorelin doesn’t carry the thyroid C-cell tumor boxed warning tied to GLP-1 receptor agonists. The mechanisms and risk profiles are different.
Drug and supplement interactions
Sermorelin affects GH and IGF-1 levels, which can interact with other hormone therapies. Categories to discuss with your prescriber:
- Glucocorticoids (corticosteroids): Suppress GH secretion and can blunt sermorelin’s effect.
- Insulin and diabetes medications: GH elevation can reduce insulin sensitivity, so dose adjustments may be needed if you’re managing blood sugar. The FDA’s compounding overview provides context on how compounded preparations are regulated differently from approved drugs, which is relevant when coordinating compounded sermorelin with other prescribed therapies.
- Other GH-axis peptides (GHRPs like ipamorelin): Combination protocols are common but require prescriber oversight.
- Thyroid medications: Changes in thyroid medication can affect GH axis responsiveness and how well sermorelin works.
Share a full medication and supplement list with your prescriber before starting.
Stopping the medication
There’s no large randomized trial dataset on stopping sermorelin in adult wellness use. What we know comes from the mechanism: sermorelin stimulates your own GH production rather than replacing it. The pituitary axis isn’t suppressed the way it can be with exogenous HGH. GH axis function generally returns to pre-treatment baseline after stopping.
That means the wellness benefits (energy, body composition, sleep) tend to fade as GH levels settle back. Some prescribers taper. Others stop directly. Either way, talk through a stopping plan before you start.
Cost and Access
Cost ranges as of May 2026. Pricing varies by pharmacy and shortage status; confirm with the dispensing pharmacy before committing to a multi-month plan.
Typical cost
Compounded sermorelin runs roughly $100 to $300 per month out of pocket. The original FDA-approved branded version was voluntarily withdrawn from the US market and isn’t currently available, so there’s no branded comparator. Insurance coverage for compounded medications is uncommon.
Cost breakdown by pharmacy tier
Pricing varies by pharmacy type, dose, and formulation:
| Tier | Typical monthly cost | Notes |
| 503A compounded (single-patient) | $100 to $250 | Prescription-specific; insurance rarely covers |
| 503B compounded (outsourcing facility) | $150 to $350 | Available through clinics; FDA-registered, cGMP-compliant oversight |
| FDA-approved branded version | Not currently available | Voluntarily withdrawn from the US market |
Prices shift based on dose, formulation, and which pharmacy fills the prescription. Get a current quote from the pharmacy your prescriber works with.
Compounded vs branded pricing
Because the original FDA-approved branded version is no longer on the market, sermorelin’s pricing landscape is compounding-only. That’s different from GLP-1 treatments, where a branded comparator still exists. What drives your cost: whether the pharmacy is a 503A (single-patient) or 503B (outsourcing facility) operation, your prescribed dose, and the formulation (injectable vs. sublingual or nasal spray).
How to get it
Sermorelin requires a prescription from a licensed provider. The most common routes are telehealth platforms that send prescriptions to compounding pharmacies, and in-person functional medicine or hormone health clinics. Look for providers who specialize in hormone health or longevity medicine if you need someone near you.
Frequently Asked Questions
Sources
Mayo Clinic. Sermorelin (Injection Route): Description and Brand Names. Updated February 2026.